Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 2/20 | 0.57 |
| ▸ | OTC | P00480 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | ARG2 | P78540 | 4/20 | 0.37 |
| ▸ | ARG1 | P05089 | 3/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28297586 | 1.00 | DDAH1 (0.57) | DDAH1OTCGSRMEN1GAA | |
| SCHEMBL7194971 | 1.00 | DDAH1 (0.57) | DDAH1OTCGSRMEN1GAA | |
| SCHEMBL9966613 | 0.95 | DDAH1 (0.52) | DDAH1OTCGSRSLC1A3SLC1A1 | |
| SCHEMBL458808 | 0.95 | DDAH1 (0.52) | DDAH1OTCGSRSLC1A3SLC1A1 | |
| SCHEMBL30033086 | 0.95 | DDAH1 (0.52) | DDAH1OTCGSRSLC1A3SLC1A1 | |
| Hydrochloric Acid SCHEMBL30096368 | 0.94 | DDAH1 (0.51) | DDAH1OTCGSRSLC1A3SLC1A1 | |
| SCHEMBL24185361 | 0.91 | DDAH1 (0.46) | DDAH1OTCGSRKMT2ASLC1A3 | |
| SCHEMBL22281181 | 0.87 | DDAH1 (0.43) | DDAH1MEN1GAAKMT2ADPP8 | |
| SCHEMBL10078341 | 0.84 | DDAH1 (0.41) | DDAH1MEN1GAAKMT2ADPP7 | |
| SCHEMBL16093029 | 0.84 | DDAH1 (0.41) | DDAH1MEN1GAAKMT2ADPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109847107-B | Medical artificial joint material and preparation method thereof | 湖南博隽生物医药有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-109837090-B | Saline-alkali soil remediation method | 广东宜瑞环境科技有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-112402698-A | Antioxidant wear-resistant medical artificial joint material | 湖南博隽生物医药有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-109847107-A | Medical artificial joint material and preparation method thereof | 湖南博隽生物医药有限公司 | 2019-06-07 | — | — | CN | claimed |
| CN-109845898-A | A kind of additive for farm animal feed and preparation method thereof | 朱美 | 2019-06-07 | — | — | CN | claimed |
| CN-109837090-A | A kind of restorative procedure of salt affected soil | 广东宜瑞环境科技有限公司 | 2019-06-04 | — | — | CN | claimed |
| US-11231424-B2 | Levetiracetam immunoassays | ARK DIAGNOSTICS, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| CN-109847107-B | Medical artificial joint material and preparation method thereof | 湖南博隽生物医药有限公司 | 2021-09-03 | — | — | CN | disclosed |
| CN-109837090-B | Saline-alkali soil remediation method | 广东宜瑞环境科技有限公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-112402698-A | Antioxidant wear-resistant medical artificial joint material | 湖南博隽生物医药有限公司 | 2021-02-26 | — | — | CN | disclosed |
| US-20200240991-A1 | Levetiracetam Immunoassays | ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT | 2020-07-30 | — | — | US | disclosed |
| CN-109847107-A | Medical artificial joint material and preparation method thereof | 湖南博隽生物医药有限公司 | 2019-06-07 | — | — | CN | disclosed |
| CN-109845898-A | A kind of additive for farm animal feed and preparation method thereof | 朱美 | 2019-06-07 | — | — | CN | disclosed |
| CN-109845898-A | A kind of additive for farm animal feed and preparation method thereof | 朱美 | 2019-06-07 | — | — | CN | disclosed |
| CN-109837090-A | A kind of restorative procedure of salt affected soil | 广东宜瑞环境科技有限公司 | 2019-06-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200240991-A1 | Levetiracetam Immunoassays | GABRG1, GABRA6, LY96 | DDAH1 2803/4885OTC 298/4885GSR 2135/4885 |
| US-11231424-B2 | Levetiracetam immunoassays | GABRG1, GABRA6, LY96 | DDAH1 2803/4885OTC 298/4885GSR 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.